The committee is hosted via the PrescQIPP CIC, and funded by East of England CCGs.
PAC provides high quality, consistent and transparent evidence-based prioritisation recommendations on medicines and technologies where NICE Technology appraisals (TA) do not exist.
The committee also produces resources to support the implementation of NICE technology appraisals and guidance, and to manage the safe and appropriate entry of new drugs pre NICE appraisals.
While the committee's remit is to support East of England CCGs, all NHS organisations are welcome to use PAC resources
The PAC work plan is continually reviewed to ensure that it remains responsive to in year developments and to the needs of East of England CCGs
Evidence reviews and commissioning recommendations currently in development:
Myodysplastic syndrome - management of
Insulin pumps and continuous glucose monitoring
Doxylamine/pyridoxine - nausea and vomiting in pregnancy
Dimethyl fumarate - psoriasis
Contact Joanne Lowe, PAC Lead Pharmacist email@example.com